New research claims sufficiency of vitamin D reduces COVID-19 severity
Category: #health  | By Nikita Chaurasia  | Date: 2020-09-29 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

New research claims sufficiency of vitamin D reduces COVID-19 severity

According to a recent study, COVID-19 patients having sufficient levels of vitamin D, with at least 30 ng/mL of 25-hydroxyvitamin D in their blood, are less likely to witness severe clinical outcomes and deaths.

The study, which was published by the Boston University School of Medicine in the journal ‘PLOS One’, also revealed that the patients showcased higher blood levels of lymphocytes and low levels of an inflammatory marker C-reactive protein.

Sources close to the matter state that the study included around 235 hospitalized COVID-19 patients, and were strictly monitored to observe key parameters such as clinical severity of the virus along with respiratory issues resulting in hypoxia and death.

This was followed by a comparative study of the blood samples with those of the subjects having sufficient vitamin D levels, sources claimed.

The research team reportedly witnessed that patients above the age of 40 years with enough vitamin D levels have 51.5% lower chances of dying as compared to those with blood levels of 25-hydroxyvitamin D lower than 30 ng/mL.

Michael F. Holick, a professor of medicine, physiology and biophysics and molecular medicine at Boston University, who published the study, was reported saying that the research evidently concludes that vitamin D sufficiency can not only lower the risk of complications such as cytokine storm but also can help in reducing mortality rates among COVID-19 patients.

Expressing his concerns regarding the potential surge in COVID-19 hospitalization, Holick added that the new study will provide a convenient and cost-effective strategy for addressing the adverse effects of the pandemic.

In other news, a recent study by researchers at the University of Birmingham reportedly stated that dried blood spot samples (DBS) could be used as an inexpensive alternative for testing blood while detecting COVID-19 antibodies.

Source credits: https://scitechdaily.com/sufficient-levels-of-vitamin-d-significantly-reduces-complications-death-among-covid-19-patients/

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Goldman Sachs provides unlimited holidays to its senior employees

Goldman Sachs provides unlimited holidays to its senior employees

By Nikita Chaurasia

Goldman Sachs has recently announced a flexible vacation scheme under which the company’s senior employees can take unlimited paid leaves annually. As per sources, the global investment bank has unveiled a new policy that will allow senior sta...

Shell trades off Russian retail business to native oil producer Lukoil

Shell trades off Russian retail business to native oil producer Lukoil

By Nikita Chaurasia

Energy giant Shell plans on selling more than 400 petrol stations of its Russian subsidiary Shell Neft to Lukoil, the second largest oil producer in the country after state backed Rosneft. As several Western oil and gas firms seek to get rid of th...

Mitsubishi, Siemens sign an MoU to cooperate in SiC traction technology

Mitsubishi, Siemens sign an MoU to cooperate in SiC traction technology

By Nikita Chaurasia

Mitsubishi Electric Europe and Siemens Mobility have recently signed a memorandum of understanding (MoU) to work together in silicon carbide (SiC) traction power technology. As per reports, JR Central’s next-generation N700S Shinkansen train...